๐Ÿ•ต๏ธ Carisma Therapeutics Inc. ($CARM)

SEC insider & ownership activity, last 12 months ยท CIK 1485003 ยท every row links its SEC filing

Over the last 12 months insiders sold $139K with no open-market buying against it. Michael Klichinsky sold $139K (Oct). 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Dec 4, 2025.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net -$139K Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) ยท 1 seller, $139K (4 lots)

InsiderBuysBoughtSellsSoldLast
Michael Klichinsky0โ€“ 4$139KOct 7, 2025

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Michael Klichinsky$14KOct 7, 2025 filing โ†—
Michael Klichinsky$134KSep 30, 2025 filing โ†—

Material events (8-K)

ItemEvent date
Delisting notice (3.01)Dec 4, 2025 filing โ†—
Officer/director changes (5.02)Dec 4, 2025 filing โ†—
Officer/director changes (5.02)Oct 14, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 14, 2025 filing โ†—
Delisting notice (3.01)Oct 9, 2025 filing โ†—
Material agreement (1.01)Sep 16, 2025 filing โ†—
Agreement terminated (1.02)Sep 16, 2025 filing โ†—
Other events (8.01)Sep 16, 2025 filing โ†—
Material agreement (1.01)Aug 29, 2025 filing โ†—
Unregistered equity sale (3.02)Aug 29, 2025 filing โ†—
Change of control (5.01)Aug 29, 2025 filing โ†—
Officer/director changes (5.02)Aug 29, 2025 filing โ†—
Other events (8.01)Aug 29, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 29, 2025 filing โ†—
Shareholder vote (5.07)Aug 5, 2025 filing โ†—